Is sermorelin the same as HGH?
No. Sermorelin stimulates your pituitary to release growth hormone. Direct HGH replaces the hormone itself. Your clinician chooses based on goals and labs.
Sermorelin Guide
A patient-friendly education resource for clinician-guided sermorelin therapy.
Sermorelin is a growth hormone–releasing hormone (GHRH) analog used in clinician-guided peptide protocols to support the body’s own growth hormone signaling pathways.
At Vita Bella, sermorelin is prescribed only after licensed provider review of goals, labs, and risk.
Sermorelin can stimulate pituitary release of growth hormone, which then influences IGF-1 and recovery/metabolic pathways.
It is different from direct HGH administration. Your clinician chooses the pathway based on labs and goals.
Clinicians may discuss sermorelin for recovery, body composition support, sleep-related recovery, or age-related decline in GH signaling when appropriate.
It is not a substitute for diagnosing sleep apnea, thyroid disease, or other root causes of fatigue.
Candidates are typically adults with clinician-guided performance, recovery, or wellness goals after evaluation.
Active malignancy concerns, uncontrolled diabetes, pregnancy, or other red flags may exclude therapy.
Evaluation may include IGF-1, metabolic labs, and other markers your clinician selects — timing matters for interpretation.
Your provider may compare sermorelin with tesamorelin or other peptide options based on goals.
Sermorelin is commonly used as a subcutaneous injectable with individualized dosing and schedule (often evening).
Reconstitution, units, and frequency come from your pharmacy label and clinician instructions — not internet protocols.
Use sterile technique, rotate sites, and follow Vita Bella injection resources for subcutaneous peptides.
Store reconstituted peptide as directed. Discard according to pharmacy dating guidance.
Possible effects include injection-site redness, flushing, headache, or transient water retention.
Report unusual swelling, severe joint pain, vision changes, or signs of high blood sugar promptly.
Discuss cancer history, diabetes risk, and concurrent peptides/hormones before starting.
Quality compounding and clinician monitoring are essential for peptide therapy.
No. Sermorelin stimulates your pituitary to release growth hormone. Direct HGH replaces the hormone itself. Your clinician chooses based on goals and labs.
Both relate to GH-axis signaling but have different clinical profiles and use cases. Your provider can explain which fits your goals better.
Sleep, recovery, or body-composition shifts — if they occur — may take weeks. Expectations should be set with your care team.
Start with a Vita Bella membership consultation so a licensed provider can review labs, recovery goals, and whether sermorelin or another peptide pathway is right for you.